Abbott teams up with Novo Nordisk to boost semaglutide access in India; key details insideAbbott teams up with Novo Nordisk to boost semaglutide access in India; key details inside

Introduction

Leading healthcare and pharmaceutical companies collaborate to launch a new semaglutide therapy in India, providing type 2 diabetes patients access to effective blood sugar, weight, and heart care benefits.

Also Read: Mastek wins £49m Home Office biometrics project in the UK

Share price movement of Abbott India

On March 2, 2026, Abbott India Ltd opened at ₹26,000.00, up 1.28% from its previous close of ₹26,495.15. The stock reached a high of ₹26,883.20 (1.48%) and a low of ₹26,000.00. By 1:45 PM, it traded at ₹26,835.00, a 1.28% increase, with a market cap of ₹57,022.50 crore.

Abbott India Partners with Novo Nordisk

Abbott India and Novo Nordisk India announced a collaboration to launch Extensior®, a semaglutide-based therapy for type 2 diabetes, expanding access to modern evidence-based treatments across India.

Under the agreement, Abbott will commercialize Novo Nordisk’s semaglutide (Ozempic®) under the brand name Extensior®. The therapy offers HbA1c reduction, weight-loss benefits, and reduced cardiovascular and kidney risks in type 2 diabetes patients.

Extensior® is approved as an adjunct to diet and exercise for adults with type 2 diabetes. Semaglutide has been used globally for nearly a decade with over 49 million patient years of data.

Stock performance of Abbott India for period of 1 week, 6 months, and 1 year

Abbott India Ltd delivered a 0.23% return over the past week, declined 18.6% in the past 6 months, and dropped 12.7% over the past 1 year.

Also Read: Marine Electricals bags Rs 27.49 crore orders from CG Semi & Oberoi Realty

Shareholding pattern of Abbott India

Particulars	Dec 2025	Sep 2025	Jun 2025
Promoter	75.00%	75.00%	75.00%
FII	0.20%	0.20%	0.20%
DII	9.00%	9.10%	9.20%
Public	15.80%	15.70%	15.70%

About Abbott India

Abbott India Ltd (NSE: ABBOTINDIA) is a leading healthcare company offering diagnostics, medical devices, nutrition, and medicines, serving over 12,000 employees across urban and rural India.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs